Global health trial tests if costly new insulin is worth it for kids in need
NCT ID NCT05614089
Summary
This study tested whether a newer, more expensive insulin (glargine) works better than older, cheaper human insulin for young people with type 1 diabetes in low-resource settings. Researchers enrolled 400 participants aged 7-25 to compare how well each insulin controls blood sugar levels and reduces dangerous low blood sugar events. The goal was to provide evidence to help health organizations decide which insulin to recommend for communities with limited resources.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
BIRDEM Hospital
Dhaka, Bangladesh
-
Bugando Medical Center
Mwanza, Tanzania
-
Sekou-Toure Hospital
Mwanza, Tanzania
Conditions
Explore the condition pages connected to this study.